Ten crossbred (Suffolk X Rambouillet) whether Iambs were randomly assigned to receive 0 or 10 ppm cimaterol (CIM) in a completely mixed high-concentrate diet for 8 wk. Total weight gain and feed efficiency were improved 29% (P<.05) and 14%, respectively, in the CIM-fed group. CIM also improved (P<.O1) dressing percent by 4.9 percentage points and improved yield grade by one grade. CIM increased longissimus muscle (LD) area 38% (P<.O1) and the yield of four lean cuts 28% (P<.01). No difference was found in the proportion of type I (slow-contracting, oxidative) and type II (fast-contracting, mixed glycolytic/oxidative) fibers in LD and semitendinosus (ST) muscles between control and CIM groups, indicating no change in fiber type. The cross-sectional area of type II fibersin LD and ST muscles of the CIM group was 2,081 and 1,951 /~m 2 as compared with 1,391 and 1,296 #m a of the control group, respectively. The increase was approximately 50% (P<.01). No difference was found in cross-sectional area of type I fibers, indicating that the increase of muscle mass was due to hypertrophy of type II fibers only. DNA concentration (~g/g wet muscle or gg/g protein) of CIM muscle was much lower (P<.01) than that of control muscle, suggesting that the protein accretion in muscle was accomplished without additional incorporation of nuclei from satellite cells.
Introduction
Recently, it has been shown that the betaadrenergic agonists improve animal growth performance or carcass composition. Feeding the beta -2-adrenergic agonist, clenbuterol, demonstrated significant improvement in feed efficiency and carcass composition in finishing lambs and broilers (Dairymple et al., 1984) . Carcass composition was significantly improved in finishing steers receiving dietary administration of clenbuterol without affecting rate of gain or feed efficiency . Chronic treatment of clenbuterol and fenoterol also caused hypertrophy of muscle without any effect on fat deposition in rats (Emery et al., 1984) . Other investigators (Berne et al., 1985; Rothwell and Stock, 1985) reported a significantly decreased fat deposition along with muscle hypertrophy in clenbuterol-fed rats. Cimaterol, an analogue of clenbuterol, has also been found to increase 1 Dept. Anita. Sci. 2 American Cyanamid Co., Princeton, NJ. Received January 27, 1987 . Accepted June 3, 1987 lean tissue and decrease adipose tissue accretion in finishing swine (Jones et al., 1985) and lambs Beermann et al., 1986) .
Results from the cited papers emphasize the improvement of growth performance and carcass characteristics; limited information is available on muscle fiber characteristics. Beermann et al. (1985b) reported fiber type changes in cimaterol-fed lambs in the semitendinosus muscle but not in the semimembranosus or longissimus muscles. They also concluded that the cimaterol-induced hypertrophy of the hind leg muscles resulted from an equivalent radial hypertrophy of both type I and type II fibers. In a study with clenbuterol-fed rats, Maltin et al. (1986) suggested that in both soleus and extensor digitorium longus muscles, clenbuterol treatment led to an increase in the functional area capable of glycolytic metabolism accompanied by a decrease in slow twitch fibers.
The objective of the present study was to study further the effects of cimaterol on growth, carcass characteristics and skeletal muscle fiber type, and the relationship of fiber hypertrophy to DNA concentration. 
Materials and Methods
Ten crossbred (Suffolk • Rambouillet) whether lambs weighing approximately 34.5 kg were randomly assigned to two treatment groups; control and cimaterol-fed (CIM). Animals were fed ad libitum a high-concentrate diet (table 1) with or without 10 ppm cimaterol for 8 wk. Animals were weighed every 2 wk after an overnight withdrawal of feed and water (shrunk weights). Feed consumption was measured over an 8-wk period.
After 8 wk, all animals were slaughtered and the following carcass measurements were made: hot carcass weight, chilled carcass weight, liver and heart weight, depth of fat and longissimus muscle area at the 12th rib, kidney and pelvic fat weight, leg conformation, flank streaking and feathering, and color and firmness of longissimus muscle at the 12th rib. Firmness was subjectively measured on an 8-point numerical value system described by Boggs and Merkel (1979) . Color was also subjectively determined on a 5-point scale; I = pale, 2 = slightly pale, 3 = bright red, 4 = slightly dark and 5 = dark. USDA quality and yield grades were determined as described by Boggs and Merkel (1979) .
Body composition was estimated from carcass density using the second set of regression equations (II Lambs) developed by Rattray et a1.(1973) . All carcasses were fabricated into wholesale cuts and the yields of leg, loin, rack 3 Reichert Visopan, C. Reichert Optical Co., Wien, Austria.
4 MOP Digital Image Analyzer, Carl Zeiss Inc., New York, NY. and shoulder were determined. The gastrocnemius muscle was also isolated and weighed.
For the cytological analysis, the longissimus (LD) and semitendinosus (ST) muscle samples taken from the geometrical center of each muscle were frozen in dry ice-acetone. Sections were cut in a cryostat and then stained for myofibriUar adenosine triphosphatase (ATPase) after acid incubation at pH 4.2, as described by Guth et al. (1970) . The sections were projected on a projection microscope 3 and all the fibers in several microscopic fields were traced. Approximately 500 fibers were traced for a given muscle sample. During the tracing, type I (slow-contracting, oxidative) and type II (fastcontracting, mixed glycolytic/oxidative) fibers were identified. The proportions of fiber type were calculated by counting the number of each fiber type from the tracings. Individual fiber cross-sectional area was also determined from the tracings using a Zeiss MOP Digital Image Analyzer a and average cross-sectional area was calculated.
Subcutaneous adipose tissue from the 12th rib and kidney fat depot were taken for the measurement of adipose cell size. The samples were taken at identical locations on each lamb to prevent any sampling variations. Thin slices of adipose tissue were fixed in osmium tetroxide and processed-according to the method of Hirsch and GaUian (1968) . Individually separated adipose cells were placed on a microscopic slide and approximately 300 adipose cells for each animal were traced using a projection microscope 3. Adipose cell sizes were then determined using a Zeiss MOP 4 .
For the analysis of DNA concentration, about 10 gm of LD and ST muscle samples taken at mid-length and from the total crosssection were frozen in liquid nitrogen and were pulverized according to the method of Bochert and Briskey (1965) . A .2-to .25-g sample of pulverized muscle was homogenized in 10 ml of .9% NaC1 solution for 1 rain at high speed using a polytron homogenizer. The nucleic acids were separated from the homogenate as described by Munro and Fleck (1966) , and DNA concentration was determined using the Cerriotic procedure (Cerriotti, 1952) . Duplicate .1-ml aliquots of homogenates were used to determine the protein concentration by the method of Lowry et al. 1951 ).
Blood samples were collected from the jugular vein after overnight fasting at the beginning and at the completion of experiment. Plasma free fatty acids (FFA) were determined by pre-extraction and microtitration of FFA with .01N tetrabutylammonium hydroxide (Kelly, 1965) . Plasma triglycerides were measured enzymatically using Fisher Diagnostics Triglyceride (500 nm) Enzyme Kit s . Statistical analysis of all data was conducted using Student's t-test of Statistical Analysis System (SAS, 1982) .
Results
The effects of cimaterol on the performance of lambs are summarized in table 2. Total weight gain and feed/gain were improved by 29 (P<.05) and 14%, respectively, in the CIM group. The improved gain resulted in heavier (P<.05) final live weight and heavier (P<.01) carcass weight. The higher dressing percentage (P<.01) of the CIM group was attributed to heavier muscling. Though statistically not significant, both liver and heart weights were lower in the CIM group, indicating that hypertrophy manifested in the skeletal muscle was not observed in the internal organs. Table 3 summarizes the effect of cimaterol on carcass characteristics and body composition. Parameters indicating the fatness of the carcass, flank streaking, backfat thickness and kidney s Fisher Enzyme Kit, Fisher Scientific, Fair Lawn, NJ.
and pelvic fat showed lower values in the CIM group, but the differences were not statistically significant. The longissimus muscles of the CIM group were firmer but lighter in color as compared with the control group. The most obvious difference was found in muscling as evidenced by higher (P<.01) leg conformation and greater (P<.01) longissimus muscle area in the CIM group. A marked difference in carcass conformation is illustrated in figure 1. The longissimus muscle area increased by 38.5% and leg conformation was improved by one grade (Choice in control vs Prime in C1M). Because of the greater muscling and better conformation, USDA yield grade and final quality grade were also improved (P<.05).
Though statistically not significant, body composition calculated from carcass density showed increased accretion of protein and decreased deposition of fat in the CIM group. It appeared that the regression equations derived from the normally fed lambs (Rattray, 1973) were not adequate for the C1M-fed lambs (Y. S. Kim, personal communication), which would explain why no significant difference was found in body composition.
As shown in table 4, yields of four lean primal cuts were significantly increased in response to cimaterol. The extent of improvement was most in the leg (29.5%), followed by the rack (28.4%), shoulder (25.8%) and loin (23.6%). The increase in the total yield of four primal cuts (27.5%) was greater than the dTends to be moderately firm=5, moderately firm=6, tends to be firm=7.
Prime =15, Prime =14, Prime-=13, Choice+=12, Chmce =11, Choice =10, Good+=9, Good =8, Good =7.
fPrime-=13, Choice+=12, Choice~ Choice-=10, Good+=9.
gBody compositions were calculated from the carcass density using regression equations.
9 P<.05, differs from control. 9 *P<.01, differs from control.
increase of carcass weight (21.4%), indicating t h a t a heavier muscling in these cuts was responsible for the additional i m p r o v e m e n t of primal cuts yield. The gastrocnemius muscle weight was 40% greater in the ClM group than in control, which is the same e x t e n t of increased growth as seen in LD muscle area (38.5%). The skeletal muscle fiber types, fiber sizes and D N A c o n c e n t r a t i o n s are s u m m a r i z e d in table 5. No difference was f o u n d in the proportion of type I and type I1 fibers in LD and ST muscles b e t w e e n control and CIM groups. The cross-sectional areas of t y p e 11 fibers in LD and ST muscles of the CIM group were 2,081 and 1,951 /am 2 as compared with 1,391 and 1,296 /am 2 of control LD and ST muscles, respectively. This increase was a p p r o x i m a t e l y 50% (P<.01). No difference was f o u n d in crosssectional areas of type I fibers, indicating t h a t the increase of muscle mass in C1M group was due to the h y p e r t r o p h y t y p e II fibers only. The muscles. We did not measure the weight of LD and ST muscles, but if we assume roughly 40% hypertrophy in the CIM group, as evidenced by LD cross-sectional area and gastrocnemius muscle weight, then the total DNA content in muscles would be almost identical between control and CIM group. Thus, the DNA data suggest that the hypertrophy of skeletal muscle has been accomplished without additional incorporation of nuclei into the muscle fibers from the satellite cells.
As expected, plasma concentrations of fatty acid and triglyceride increased with the feeding of cimaterol (table 6) . Triglyceride concentration was two times higher and fatty acid 24% higher in the CIM group. Both subcutaneous and kidney fat adipocytes were much smaller in the CIM group than in the control. The effect was more pronounced in subcutaneous fat than in kidney fat.
Discussion
The improvement of animal performance and carcass characteristics with the administration of cimaterol in this study are in accord with other reports that have studied the effects of beta-agonists on the performance and carcass traits of Iambs Beermann et al., 1986) . It is likely that the improved feed efficiency and gain were achieved by a successful repartitioning of energy from fat to muscle, which probably resulted from the administration of beta-agonists. Even though the energetic efficiency of protein deposition is lower than fat formation (Thorbek, 1977) , the total costs of energy (energy content of tissue plus heat loss associated with tissue gain) for deposition of fat or protein are the same at about 12.7 Mcal/kg (Trenkle and Marple, 1983) . Thus, the energy efficiency for deposition of a unit weight of muscle is much higher than that of fat since muscle is composed of 70% water. This suggests that the successful repartitioning of energy from fat to muscle can lead to an improvement in animal growth rate and feed efficiency (Etherton and Meserole, 1982) . One of the major findings in this study was that the increased muscle accretion was due to the hypertrophy of type II fibers. In a study with rats, Deschaies et al. (1981) also reported that isoproterenol induced hypertrophy of the tibialis, a mixed muscle of type I and II fibers, whereas it did not affect the weight of the soleus, muscle of mainly type I fibers. On the other hand, other investigators (Maltin et al., 1986; Reeds et al., 1986; Zeman et al., 1987) reported an increased weight gain in soleus muscle equivalent to that observed in muscles with mixed fiber populations in clenbuterol-fed normal rats and rats denervated by sciatic nerve section. Beermann et al. (1985b) also reported an equivalent radial hypertrophy of type I and type II fiber in cimaterolfed lambs. Although no explanation to the contradicting reports on the response of different muscles or fiber types to beta-agonists can be given at present, several factors including the length of feeding period (Maltin et al., 1986) and the strain or breed of animals (Berne et al., 1985) can affect the results.
Lamb muscles contained 10% or less type I fibers, and cimaterol feeding further reduced percent type I fibers (Beermann et al., 1985a) . This means that cimaterol-induced muscle growth is clearly the result of the hypertrophy of type II fibers. Maltin et al. (1986) also suggested that in both soleus and extensor digitorum longus muscles of rats, clenbuterol treatment led to an increase in the functional area capable of glycolytic metabolism accompanied by a decrease in slow twitch fibers.
Another interesting finding of this study is that the DNA concentration per unit amount of muscle or per unit amount of protein was lower (P<.01) in cimaterol-fed animals compared to control group. Beermann et al. (1985a) also reported a lower concentration of DNA (25% less) in cimaterol-fed lambs at 7 wk of feeding, although at 12 wk there was no difference between control and treated lambs. The total muscle DNA content was only slightly higher (5.9%) in cimaterol-fed lambs in spite of a 35% increase in muscle weight at 7 wk. These resuits suggest that the increase of DNA is not a prerequisite for beta-agonist-induced hypertrophy of muscle. It contradicts the traditional theory of constant DNA unit size, i.e., each nucleus within the muscle fiber has jurisdiction over a finite mass of cytoplasm and the number of nuclei per muscle increases as the muscle grows to keep the ratio of DNA to muscle fiber cytoplasm constant (Enesco and Puddy, 1964; Cheek et al., 1971) . In other words, the increase of DNA is a prerequisite to the protein synthesis associated with normal growth (Burleigh, 1974; Allen et al., 1979) , compensatory growth (Howarth and Baldwin, 1971 ) orstretch-induced growth (Barnett et al., 1980) . The simplest explanation for the unique nature of beta-agonists -induced hypertrophy would be that beta-agonists might have decreased protein degradation without affecting protein synthesis, resulting in greater muscle mass with decreased DNA concentration per unit muscle. In fact, Li and Jefferson (1977) reported that isoproterenol, a beta-agonist, did not affect protein synthesis but only decreased protein catabolism. More recently, Reeds et al. (1986) also reported that although clenbuterol increased the rate of protein and RNA accretion in gastrocnemius and soleus muscles, protein synthesis was not increased. They further suggested that clenbuterol appeared to have a rapid, perhaps direct, inhibitory effect on protein degradation. However, other investigators (Emery et al., 1984) have reported elevated fractional protein synthesis in rat gastrocnemium muscle after daily injection of clenbuterol or fenoterol. Our recent study (unpublished data) showed that an increase in RNA concentration always preceded a larger gain of muscle weight in the CIM group. Beermann et al. (1985a) also reported that a 35% and 25% greater RNA content was associated with the same relative increases in semitendinosus weight observed with 6-and 12-wk cimaterol treatment, respectively. Although these data suggest that capacity for protein synthesis is increased, neither an increase in muscle protein specific mRNA nor increased translation rate has been demonstrated. Further study to elucidate the precise mode of action is warranted.
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